Striatal Dopamine in Bulimia Nervosa: a PET Imaging Study
Overview
Authors
Affiliations
Objective: Bulimia nervosa (BN) has been characterized as similar to an addiction, though the empirical support for this characterization is limited. This study utilized PET imaging to determine whether abnormalities in brain dopamine (DA) similar to those described in substance use disorders occur in BN.
Method: PET imaging with [(11) C]raclopride, pre/post methylphenidate administration, to assess dopamine type 2 (D(2)) receptor binding (BP(ND)) and striatal DA release (ΔBP(ND)).
Results: There was a trend toward lower D(2) receptor BP(ND) in two striatal subregions in the patient group when compared with the control group. DA release in the putamen in the patient group was significantly reduced and, overall, there was a trend toward a difference in striatal DA release. Striatal DA release was significantly associated with the frequency of binge eating.
Discussion: These data suggest that BN is characterized by abnormalities in brain DA that resemble, in some ways, those described in addictive disorders.
Why Don't You Just Eat? Neuroscience and the Enigma of Eating Disorders.
Pinson C, Frank G Focus (Am Psychiatr Publ). 2024; 22(3):328-332.
PMID: 38988457 PMC: 11231469. DOI: 10.1176/appi.focus.20240006.
Dougherty E, Bottera A, Forester G, Schaefer L, Forbes E, Wildes J Psychiatry Res. 2024; 332:115717.
PMID: 38183925 PMC: 10872327. DOI: 10.1016/j.psychres.2024.115717.
The Role of the Endocannabinoid System in Binge Eating Disorder.
Bourdy R, Befort K Int J Mol Sci. 2023; 24(11).
PMID: 37298525 PMC: 10253843. DOI: 10.3390/ijms24119574.
A critical analysis of eating disorders and the gut microbiome.
Terry S, Barnett J, Gibson D J Eat Disord. 2022; 10(1):154.
PMID: 36329546 PMC: 9635068. DOI: 10.1186/s40337-022-00681-z.
Genetics and neurobiology of eating disorders.
Bulik C, Coleman J, Hardaway J, Breithaupt L, Watson H, Bryant C Nat Neurosci. 2022; 25(5):543-554.
PMID: 35524137 PMC: 9744360. DOI: 10.1038/s41593-022-01071-z.